Pfizer submits data for Covid-19 vaccine in younger children

Pfizer Inc and BioNTech SE on Tuesday submitted initial trial data for their Covid-19 vaccine in children aged five to 11 and said they would make a formal request with US regulators for emergency use in the coming weeks.

Coronavirus infections have soared in children in the United States, hitting their highest point in early September, according to data from the American Academy of Pediatrics.

The vaccine, which is already authorised in teens...